Open Nav

Guillermo Morales

Chief Business Officer & Director of Research

SignalRx Pharmaceuticals, Inc.

Guillermo A. Morales, PhD, MBA has 23 years of experience in chemistry and pharmaceutical R&D in positions of increasing responsibility (Director, CEO), devising and implementing strategic efforts for diverse research programs and therapeutics including cancer, CNS disorders, and anti-infectives.

Dr. Morales designed and discovered SignalRx’s compound classes from which diverse first-in-class inhibitors have emerged and are now being developed. He is also an entrepreneur with start-up co-founding experience, raising venture capital investment, leading and developing pharmaceutical programs from early drug discovery to IND ready.

Dr. Morales is the former Editor-in-Chief of the journal Molecular Diversity (11 years) and holds 11 patents (6 granted + 5 applications) and 33 publications.

Dr. Morales obtained his Ph.D. in Organic Chemistry from Louisiana State University and MBA from the Jack Welch Management Institute (Strayer University).

This speaker's sessions: